CompletedNCT01134731
Paliperidone or Lithium Added to Antidepressants for Suicidal Thoughts
About this title
Read the official source — NCT01134731Medication studyAges 19–65United StatesSuicide prevention
Understand this study
Who was this study for?
Listed age limits: 19 years to 65 years.
- Listed locations
- BirminghamSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMay 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 54
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT01134731
- Official title
Show the full official title
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alabama at Birmingham, a university.
Did this study involve medication?
Yes. The study involved medication, including paliperidone, lithium and Placebo.
Who was this study for?
Listed age limits: 19 years to 65 years.
